| Richard M Campbell Veterans Nursing Home | |
| 4605 Belton Highway, Anderson, South Carolina 29621 | |
| (864) 261-6734 | |
| Name | Richard M Campbell Veterans Nursing Home |
|---|---|
| Location | 4605 Belton Highway, Anderson, South Carolina |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 220 |
| Occupancy Rate | 80.45% |
| Medicare ID (CCN) | 425301 |
| Legal Business Name | South Carolina Dept Of Mental Health Accounting Office |
| Ownership Type | Government - State |
| NPI Number | 1730114182 |
| Organization Name | SOUTH CAROLINA DEPT OF MENTAL HEALTH ACCOUNTING OFFICE |
| Doing Business As | RICHARD M CAMPBELL VETERANS NURSING HOME |
| Address | 4605 Belton Hwy, Anderson, SC 29621 |
| Phone Number | 803-898-8405 |
News Archive
Spectranetics Corporation today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy products. ISR is caused by the re-growth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.
DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc., is combining efforts with True North Laboratory of Ann Arbor, Michigan, and Romer Labs, a leading global supplier of diagnostic solutions for food-borne pathogens, to investigate the applicability of utilizing Romer Labs' rapid diagnostic test kits to screen for food-borne pathogens and quantify mycotoxins present in cannabis.
The United States moved a step closer to major healthcare reform this weekend as the House of Representatives voted 220 to 215 to approve a plan that will, among other goals, extend coverage to an estimated 36 million people without insurance, create a government health insurance option and prohibit such contentious insurance company practices as denying coverage for those with pre-existing conditions and rescinding coverage without clear and convincing evidence of fraud.
Living in India and inhaling lungful of polluted air every day is like being a chronic smoker according to a recent report by India's State-Level Disease Burden Initiative. This partly explains why many people in urban India have a persistent dry and hacking cough even if they don't have asthma or have never smoked.
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
› Verified 1 days ago
| NPI Number | 1992756134 |
| Organization Name | SOUTH CAROLINA DEPT OF MENTAL HEALTH ACCOUNTING OFFICE |
| Doing Business As | RICHARD M CAMPBELL VETERANS NURSING HOME |
| Address | 4605 Belton Hwy, Anderson, SC 29621 |
| Phone Number | 803-898-8405 |
News Archive
Spectranetics Corporation today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy products. ISR is caused by the re-growth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.
DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc., is combining efforts with True North Laboratory of Ann Arbor, Michigan, and Romer Labs, a leading global supplier of diagnostic solutions for food-borne pathogens, to investigate the applicability of utilizing Romer Labs' rapid diagnostic test kits to screen for food-borne pathogens and quantify mycotoxins present in cannabis.
The United States moved a step closer to major healthcare reform this weekend as the House of Representatives voted 220 to 215 to approve a plan that will, among other goals, extend coverage to an estimated 36 million people without insurance, create a government health insurance option and prohibit such contentious insurance company practices as denying coverage for those with pre-existing conditions and rescinding coverage without clear and convincing evidence of fraud.
Living in India and inhaling lungful of polluted air every day is like being a chronic smoker according to a recent report by India's State-Level Disease Burden Initiative. This partly explains why many people in urban India have a persistent dry and hacking cough even if they don't have asthma or have never smoked.
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Spectranetics Corporation today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy products. ISR is caused by the re-growth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.
DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc., is combining efforts with True North Laboratory of Ann Arbor, Michigan, and Romer Labs, a leading global supplier of diagnostic solutions for food-borne pathogens, to investigate the applicability of utilizing Romer Labs' rapid diagnostic test kits to screen for food-borne pathogens and quantify mycotoxins present in cannabis.
The United States moved a step closer to major healthcare reform this weekend as the House of Representatives voted 220 to 215 to approve a plan that will, among other goals, extend coverage to an estimated 36 million people without insurance, create a government health insurance option and prohibit such contentious insurance company practices as denying coverage for those with pre-existing conditions and rescinding coverage without clear and convincing evidence of fraud.
Living in India and inhaling lungful of polluted air every day is like being a chronic smoker according to a recent report by India's State-Level Disease Burden Initiative. This partly explains why many people in urban India have a persistent dry and hacking cough even if they don't have asthma or have never smoked.
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7036 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.85 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.01 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 91.4 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.12 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 5.03 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 4.37 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.22 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.73 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 26.5 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 81.69 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 8.82 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 33.99 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 23.66 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.31 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.66 | 95.98 |